Blog
Valuable TargetsAdvanced Tech.
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
blog-list-cover
Recent blog posts
PRKCB Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
Latest Hotspot
8 min read
PRKCB Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
13 July 2026
PRKCB target evaluation report generated from PatSnap MCP data, assessing PKC beta biology, clinical evidence, competitive context, IP, and R&D strategy.
Read →
PRKCA Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
Latest Hotspot
8 min read
PRKCA Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
13 July 2026
PRKCA target evaluation report using PatSnap MCP data, covering PKC alpha biology, clinical validation, competition, IP, and R&D strategy.
Read →
PRKAA1 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
Latest Hotspot
8 min read
PRKAA1 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
13 July 2026
PRKAA1 target evaluation report generated from PatSnap Life Sciences MCP data, assessing AMPK alpha-1 biology, validation evidence, competition, IP, and R&D recommendations.
Read →
STK11 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
Latest Hotspot
8 min read
STK11 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
13 July 2026
STK11 target evaluation report built with PatSnap MCP data, reviewing LKB1/STK11 biology, clinical trial evidence, competition, IP, and R&D strategy.
Read →
TSC2 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
Latest Hotspot
8 min read
TSC2 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
13 July 2026
TSC2 target evaluation report generated from PatSnap MCP data, covering tuberin biology, mTORC1 regulation, asset landscape, clinical evidence, IP, and next-step strategy.
Read →
TSC1 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
Latest Hotspot
8 min read
TSC1 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
13 July 2026
TSC1 target evaluation report generated from PatSnap MCP data, assessing TSC complex biology, mTORC1 regulation, clinical evidence, competition, IP, and R&D strategy.
Read →
RICTOR Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
Latest Hotspot
8 min read
RICTOR Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
13 July 2026
RICTOR target evaluation report built from PatSnap Life Sciences MCP data, covering mTORC2 biology, validation gaps, competition, IP considerations, and R&D strategy.
Read →
RPTOR Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
Latest Hotspot
8 min read
RPTOR Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
13 July 2026
RPTOR target evaluation report generated with PatSnap Life Sciences MCP data, covering biology, validation evidence, clinical competition, IP and R&D strategy.
Read →
MTOR Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
Latest Hotspot
8 min read
MTOR Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
13 July 2026
MTOR target evaluation report generated with PatSnap Life Sciences MCP data, covering biology, validation evidence, clinical competition, IP and R&D strategy.
Read →
PTEN Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
Latest Hotspot
8 min read
PTEN Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
13 July 2026
PTEN target evaluation report generated with PatSnap Life Sciences MCP data, covering biology, validation evidence, clinical competition, IP and R&D strategy.
Read →
NF1 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
Latest Hotspot
8 min read
NF1 Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
13 July 2026
NF1 target evaluation report generated with PatSnap Life Sciences MCP data, covering biology, validation evidence, clinical competition, IP and R&D strategy.
Read →
NRAS Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
Latest Hotspot
8 min read
NRAS Target Evaluation Report: Biology, Validation, Competition, IP, and R&D Strategy
13 July 2026
NRAS target evaluation report generated with PatSnap Life Sciences MCP data, covering biology, validation evidence, clinical competition, IP and R&D strategy.
Read →